Added to YB: 2026-01-13
Pitch date: 2026-01-09
ICCC [neutral]
ImmuCell Corporation
+1.14%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
Market Cap
$58.8M
Pitch Price
$6.59
Price Target
N/A
Dividend
N/A
EV/EBITDA
11.54
P/E
25.16
EV/Sales
2.47
Sector
Biotechnology
Category
growth
Show full summary:
Phenom Capital 2025 Portfolio Update - Part [2/2] - ImmuCell Corporation
ICCC (trimmed position): Paused Re-Tain investment after FDA 'Incomplete Letter' - redirecting cash to expand First Defense manufacturing & 50% sales force growth. New CEO/CFO shed sunk-cost trap, creating 'GoodCo' play focused on crown jewel business with clear growth path.
Read full article (1 min)